Khadiga Mohamed Kelani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khadiga Mohamed Kelani has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Gamal A. Omran
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt
4 shared publicationsSamir Morshedy
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt
4 shared publicationsAhmed R. Mohamed
Pharmaceutical Chemistry Department, Faculty of Pharmacy Egyptian Russian University Badr City Cairo Egypt
3 shared publicationsWael Talaat
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Damanhour University, Cairo, Egypt
3 shared publicationsAhmed M. Wafaa Nassar
Postgraduate Program in Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Damanhour University, Cairo, Egypt
2 shared publicationsAsmaa G. Gad
Postgraduate Program in Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, El-Kasr El-Aini Street, Cairo, 11562, Egypt
2 shared publications
Latest Publications
- Open Access
- 5 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Fedorov algorithm–optimized chemometric spectrophotometry for cefepime–tazobactam microanalysis in plasma and pharmaceuticals with integrated MA and NQS sustainability assessment
A green, sustainability-oriented chemometric-assisted UV spectrophotometric platform was developed for the simultaneous determination of Cefepime (CFPM) and Tazobactam (TAZO) in pharmaceutical formulations and human plasma. Water served as the sole diluent, eliminating hazardous organic solvents and substantially reducing the environmental impact of the analytical procedure. Calibration and validation sets were efficiently constructed using the Fedorov exchange algorithm within Brereton’s multilevel design framework, yielding 25 calibration and 13 validation mixtures and reducing experimental workload by approximately 70% compared with conventional designs. Three complementary chemometric models were evaluated: Principal Component Regression (PCR), Firefly Algorithm–assisted Partial Least Squares (FA-PLS), and Multivariate Curve Resolution–Alternating Least Squares (MCR-ALS). Among them, MCR-ALS demonstrated superior predictive performance, with correlation coefficients exceeding 0.9998 for both analytes, minimal systematic bias confirmed by Elliptical Joint Confidence Region analysis, and high robustness across pharmaceutical and plasma matrices. Limits of detection were 0.0487 and 0.0396 µg mL –1 , while limits of quantification were 0.1476 and 0.1200 µg mL –1 for CFPM and TAZO, respectively. The method was validated in accordance with ICH guidelines and successfully applied to CEFE-MAX™ powder for injection and fortified human plasma. Matrix effect evaluation showed negligible signal suppression (− 2.35% to − 1.27%), indicating strong matrix tolerance and calibration transferability. Comparative benchmarking against reported HPLC–UV, LC–MS/MS, capillary zone electrophoresis, and UV spectrophotometric methods demonstrated that the proposed approach achieves an optimal balance of sensitivity, simplicity, and environmental sustainability. Sustainability assessment using the Multi-Color Assessment (MA), carbon footprint analysis, and the Need–Quality–Sustainability (NQS) index yielded a Whiteness Score of 83.6%, an NQS score of 90, and a low carbon footprint of 0.032 kg CO₂-eq per analysis. Overall, the developed platform provides a rapid, cost-effective, and environmentally responsible alternative for routine quality control and preliminary therapeutic monitoring of the CFPM–TAZO combination.
- 5 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessFedorov algorithm–optimized chemometric spectrophotometry for cefepime–tazobactam microanalysis in plasma and pharmaceuticals with integrated MA and NQS sustainability assessment
A green, sustainability-oriented chemometric-assisted UV spectrophotometric platform was developed for the simultaneous determination of Cefepime (CFPM) and Tazobactam (TAZO) in pharmaceutical formulations and human plasma. Water served as the sole diluent, eliminating hazardous organic solvents and substantially reducing the environmental impact of the analytical procedure. Calibration and validation sets were efficiently constructed using the Fedorov exchange algorithm within Brereton’s multilevel design framework, yielding 25 calibration and 13 validation mixtures and reducing experimental workload by approximately 70% compared with conventional designs. Three complementary chemometric models were evaluated: Principal Component Regression (PCR), Firefly Algorithm–assisted Partial Least Squares (FA-PLS), and Multivariate Curve Resolution–Alternating Least Squares (MCR-ALS). Among them, MCR-ALS demonstrated superior predictive performance, with correlation coefficients exceeding 0.9998 for both analytes, minimal systematic bias confirmed by Elliptical Joint Confidence Region analysis, and high robustness across pharmaceutical and plasma matrices. Limits of detection were 0.0487 and 0.0396 µg mL –1 , while limits of quantification were 0.1476 and 0.1200 µg mL –1 for CFPM and TAZO, respectively. The method was validated in accordance with ICH guidelines and successfully applied to CEFE-MAX™ powder for injection and fortified human plasma. Matrix effect evaluation showed negligible signal suppression (− 2.35% to − 1.27%), indicating strong matrix tolerance and calibration transferability. Comparative benchmarking against reported HPLC–UV, LC–MS/MS, capillary zone electrophoresis, and UV spectrophotometric methods demonstrated that the proposed approach achieves an optimal balance of sensitivity, simplicity, and environmental sustainability. Sustainability assessment using the Multi-Color Assessment (MA), carbon footprint analysis, and the Need–Quality–Sustainability (NQS) index yielded a Whiteness Score of 83.6%, an NQS score of 90, and a low carbon footprint of 0.032 kg CO₂-eq per analysis. Overall, the developed platform provides a rapid, cost-effective, and environmentally responsible alternative for routine quality control and preliminary therapeutic monitoring of the CFPM–TAZO combination.
- Open Access
- 31 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Novel green UPLC method with life cycle assessment for determination of favipiravir and molnupiravir drugs and environmental water samples
A novel green UPLC–SPE analytical method was developed for the simultaneous determination of Favipiravir (FVP) and Molnupiravir (MPV) in pharmaceutical and environmental water samples. The method was designed to address the analytical gap surrounding concurrent antiviral monitoring given their co-administration while minimizing solvent consumption, waste generation, and environmental impact. Water samples preparation employed a solid-phase extraction strategy optimized through systematic evaluation of sorbent type, conditioning, washing, and elution steps. Chromatographic separation was achieved using a mobile phase consisting of 0.01 M potassium dihydrogen phosphate buffer (pH 3.5) and 50% methanol (85:15, v/v), delivered at a flow rate of 0.2 mL/min with a 10 µL injection volume. This method produced sharp, well-resolved peaks with a total run time of less than 5 min. The method exhibited excellent linearity (r² ≥ 0.999), accuracy (98.56–101.19%), precision (RSD ≤ 1.8%), and recoveries of (98.97- 100.74%) across tap water, Nile River water, and pharmaceutical wastewater. Greenness was assessed using the Multi-Color Assessment (MA) platform, yielding a final whiteness score of 85.7%, which indicates a well-balanced integration of environmental, practical, analytical, and innovative attributes and supports the method’s suitability for routine application. The Analytical Eco-Scale score (77) and AGREE pictogram score (0.84) further confirm the strong environmental compatibility of the proposed method. Life cycle assessment (LCA) revealed substantial reductions in energy consumption and waste generation compared with conventional HPLC methods. Overall, the proposed UPLC–SPE approach, integrated with LCA and comprehensive greenness evaluation, represents a pioneering and environmentally informed strategy for antiviral analysis and provides a sustainable platform for future pharmaceutical residue monitoring.
- 31 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessNovel green UPLC method with life cycle assessment for determination of favipiravir and molnupiravir drugs and environmental water samples
A novel green UPLC–SPE analytical method was developed for the simultaneous determination of Favipiravir (FVP) and Molnupiravir (MPV) in pharmaceutical and environmental water samples. The method was designed to address the analytical gap surrounding concurrent antiviral monitoring given their co-administration while minimizing solvent consumption, waste generation, and environmental impact. Water samples preparation employed a solid-phase extraction strategy optimized through systematic evaluation of sorbent type, conditioning, washing, and elution steps. Chromatographic separation was achieved using a mobile phase consisting of 0.01 M potassium dihydrogen phosphate buffer (pH 3.5) and 50% methanol (85:15, v/v), delivered at a flow rate of 0.2 mL/min with a 10 µL injection volume. This method produced sharp, well-resolved peaks with a total run time of less than 5 min. The method exhibited excellent linearity (r² ≥ 0.999), accuracy (98.56–101.19%), precision (RSD ≤ 1.8%), and recoveries of (98.97- 100.74%) across tap water, Nile River water, and pharmaceutical wastewater. Greenness was assessed using the Multi-Color Assessment (MA) platform, yielding a final whiteness score of 85.7%, which indicates a well-balanced integration of environmental, practical, analytical, and innovative attributes and supports the method’s suitability for routine application. The Analytical Eco-Scale score (77) and AGREE pictogram score (0.84) further confirm the strong environmental compatibility of the proposed method. Life cycle assessment (LCA) revealed substantial reductions in energy consumption and waste generation compared with conventional HPLC methods. Overall, the proposed UPLC–SPE approach, integrated with LCA and comprehensive greenness evaluation, represents a pioneering and environmentally informed strategy for antiviral analysis and provides a sustainable platform for future pharmaceutical residue monitoring.
- 10 October 2025
- Published by Wiley in Archiv der Pharmazie
- Vol. 358 (10) , e70114
Chemometrics‐Assisted Spectrophotometric Methods for Determination of Methocarbamol and Paracetamol Along With Two Related Impurities: An Environmental Sustainability Assessment
Two multivariate calibration models were created for the concurrent estimation of methocarbamol and paracetamol in their co‐formulated pharmaceutical dosage form. These methods also enabled the detection of their impurities, p ‐aminophenol and guaifenesin. The calibration paradigms, based on principal component regression (PCR) and partial least squares (PLS), were employed to assess the drugs and their impurities. The methods demonstrated accurate simultaneous determination of methocarbamol, paracetamol, p ‐aminophenol, and guaifenesin within the concentration ranges of 20.00–80.00 µg mL −1 for methocarbamol, 20.00–60.00 µg mL −1 for paracetamol, 0.06–4.00 µg mL −1 for p‐ aminophenol, and 0.08–10.00 µg mL −1 for guaifenesin. The techniques were evaluated in accordance with ICH directions, and the outcomes confirmed the reliability and validity of the developed methods. The suggested approaches were successfully applied to analyze methocarbamol and paracetamol in their combined tablets and to quantify their related impurities. Furthermore, the environmental impact of these techniques was evaluated using a variety of metrics, assessing their greenness and whiteness alongside their practical effectiveness (blueness), with the results highlighting their superior environmental performance. Additionally, the suggested techniques' sustainability was appraised using the recently introduced NQS index, yielding a score of 67.70%, demonstrating strong alignment with sustainable analytical practices.
- 10 October 2025
- Published by Wiley in Archiv der Pharmazie
- Vol. 358 (10) , e70114
Chemometrics‐Assisted Spectrophotometric Methods for Determination of Methocarbamol and Paracetamol Along With Two Related Impurities: An Environmental Sustainability Assessment
Two multivariate calibration models were created for the concurrent estimation of methocarbamol and paracetamol in their co‐formulated pharmaceutical dosage form. These methods also enabled the detection of their impurities, p ‐aminophenol and guaifenesin. The calibration paradigms, based on principal component regression (PCR) and partial least squares (PLS), were employed to assess the drugs and their impurities. The methods demonstrated accurate simultaneous determination of methocarbamol, paracetamol, p ‐aminophenol, and guaifenesin within the concentration ranges of 20.00–80.00 µg mL −1 for methocarbamol, 20.00–60.00 µg mL −1 for paracetamol, 0.06–4.00 µg mL −1 for p‐ aminophenol, and 0.08–10.00 µg mL −1 for guaifenesin. The techniques were evaluated in accordance with ICH directions, and the outcomes confirmed the reliability and validity of the developed methods. The suggested approaches were successfully applied to analyze methocarbamol and paracetamol in their combined tablets and to quantify their related impurities. Furthermore, the environmental impact of these techniques was evaluated using a variety of metrics, assessing their greenness and whiteness alongside their practical effectiveness (blueness), with the results highlighting their superior environmental performance. Additionally, the suggested techniques' sustainability was appraised using the recently introduced NQS index, yielding a score of 67.70%, demonstrating strong alignment with sustainable analytical practices.
- Open Access
- 23 September 2025
- Published by Springer Nature in BMC Chemistry
- Vol. 19 (1) , 1-14
Development of two ion-selective sensors for determining benzydamine hydrochloride in the presence of its oxidative degradant across various matrices: greenness, whiteness, and blueness appraisals
Two sensitive and selective ion-selective electrodes (ISEs) were developed for the determination of benzydamine hydrochloride (BNZ·HCl): a conventional polyvinyl chloride (PVC) electrode and a coated graphite all solidstate ion-selective electrode (ASS-ISE). Both sensors were constructed using an ion-pair formed between BNZ⁺ and the lipophilic anion tetraphenylborate (TPB⁻), incorporated into the sensing membranes. The sensors exhibited near-Nernstian responses with slopes of 58.09 And 57.88 mV/decade, over a Linear range of 10–5–10–2 M, and detection Limits of 5.81 × 10–8M and 7.41 × 10–8 M, respectively. They demonstrated high accuracy and precision for the determination of BNZ·HCl in pure form, pharmaceutical cream, and biological fluids, with no matrix interference. The method also proved stability-indicating, successfully detecting BNZ·HCl in the presence of its oxidative degradant. Validation was performed according to ICH guidelines, and the method showed strong environmental compatibility based on greenness, whiteness, and blueness assessments, supporting its suitability for sustainable pharmaceutical analysis.
- 23 September 2025
- Published by Springer Nature in BMC Chemistry
- Vol. 19 (1) , 1-14
Open AccessDevelopment of two ion-selective sensors for determining benzydamine hydrochloride in the presence of its oxidative degradant across various matrices: greenness, whiteness, and blueness appraisals
Two sensitive and selective ion-selective electrodes (ISEs) were developed for the determination of benzydamine hydrochloride (BNZ·HCl): a conventional polyvinyl chloride (PVC) electrode and a coated graphite all solidstate ion-selective electrode (ASS-ISE). Both sensors were constructed using an ion-pair formed between BNZ⁺ and the lipophilic anion tetraphenylborate (TPB⁻), incorporated into the sensing membranes. The sensors exhibited near-Nernstian responses with slopes of 58.09 And 57.88 mV/decade, over a Linear range of 10–5–10–2 M, and detection Limits of 5.81 × 10–8M and 7.41 × 10–8 M, respectively. They demonstrated high accuracy and precision for the determination of BNZ·HCl in pure form, pharmaceutical cream, and biological fluids, with no matrix interference. The method also proved stability-indicating, successfully detecting BNZ·HCl in the presence of its oxidative degradant. Validation was performed according to ICH guidelines, and the method showed strong environmental compatibility based on greenness, whiteness, and blueness assessments, supporting its suitability for sustainable pharmaceutical analysis.
- Open Access
- 27 August 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Innovative voltammetric techniques for bumadizone analysis in pharmaceutical and biological samples: emphasizing green, white, and blue analytical approaches
There are no documented electroanalytical methods for quantifying the anti-inflammatory drug bumadizone (BUM) in pharmaceutical or biological matrices. So, a new voltammetric method was developed to determine BUM at nano concentrations in pharmaceutical forms, in the presence of its alkaline degradant, and in biological fluids. Five electrodes were tested, including three nano-reduced graphene oxide (nRGO) electrodes (5%, 15%, and 20%), a carbon paste electrode (CPE), and a 10% nRGO-modified CPE. The 10% nRGO-modified electrode showed the best performance, offering high selectivity and low detection limits, with good linearity in the concentration range of 0.9 × 102 to 15 × 102 ng mL−1. Differential pulse voltammetry successfully applied this electrode for BUM determination in various samples, achieving excellent recovery without preliminary separation. The method was validated according to ICH guidelines and compared favorably to the reference method. Its environmental impact was assessed using AGREE and Eco-scale metrics in addition to the RGB algorithm, showing superior greenness and whiteness profiles due to safer solvents and lower energy consumption, along with high practical effectiveness using the BAGI metric.
- 27 August 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Open AccessInnovative voltammetric techniques for bumadizone analysis in pharmaceutical and biological samples: emphasizing green, white, and blue analytical approaches
There are no documented electroanalytical methods for quantifying the anti-inflammatory drug bumadizone (BUM) in pharmaceutical or biological matrices. So, a new voltammetric method was developed to determine BUM at nano concentrations in pharmaceutical forms, in the presence of its alkaline degradant, and in biological fluids. Five electrodes were tested, including three nano-reduced graphene oxide (nRGO) electrodes (5%, 15%, and 20%), a carbon paste electrode (CPE), and a 10% nRGO-modified CPE. The 10% nRGO-modified electrode showed the best performance, offering high selectivity and low detection limits, with good linearity in the concentration range of 0.9 × 102 to 15 × 102 ng mL−1. Differential pulse voltammetry successfully applied this electrode for BUM determination in various samples, achieving excellent recovery without preliminary separation. The method was validated according to ICH guidelines and compared favorably to the reference method. Its environmental impact was assessed using AGREE and Eco-scale metrics in addition to the RGB algorithm, showing superior greenness and whiteness profiles due to safer solvents and lower energy consumption, along with high practical effectiveness using the BAGI metric.